Cargando…
Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation
A central mechanism of tumour progression and metastasis involves the generation of an immunosuppressive ‘macroenvironment' mediated in part through tumour-secreted factors. Here we demonstrate that upregulation of the Inhibitor of Differentiation 1 (Id1), in response to tumour-derived factors,...
Autores principales: | Papaspyridonos, Marianna, Matei, Irina, Huang, Yujie, do Rosario Andre, Maria, Brazier-Mitouart, Helene, Waite, Janelle C., Chan, April S., Kalter, Julie, Ramos, Ilyssa, Wu, Qi, Williams, Caitlin, Wolchok, Jedd D., Chapman, Paul B., Peinado, Hector, Anandasabapathy, Niroshana, Ocean, Allyson J., Kaplan, Rosandra N., Greenfield, Jeffrey P., Bromberg, Jacqueline, Skokos, Dimitris, Lyden, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423225/ https://www.ncbi.nlm.nih.gov/pubmed/25924227 http://dx.doi.org/10.1038/ncomms7840 |
Ejemplares similares
-
Id1 Represses Osteoclast-Dependent Transcription and Affects Bone Formation and Hematopoiesis
por: Chan, April S., et al.
Publicado: (2009) -
Th17 Response and Inflammatory Autoimmune Diseases
por: Waite, Janelle C., et al.
Publicado: (2012) -
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
por: Zamarin, Dmitriy, et al.
Publicado: (2017) -
Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers
por: Lee, K T, et al.
Publicado: (2004) -
TOX is a critical regulator of tumour-specific T cell differentiation
por: Scott, Andrew C., et al.
Publicado: (2019)